The scope of this session is on advance materials and devices with the focus on materials and implantable device development/characterization for the treatment of brain disorders including brain tumors and neurodegenerative diseases. Next generation biomaterials and nanomaterials are expected to revolutionize the future of medicine.

This session provides an opportunity for the medical and scientific communities to be exposed to new materials and nanotechnologies that could address one of the most devastating illnesses of the society: Disorders of the brain and neurodegeneration. Researchers and engineers will be able to learn about the clinical and patient needs from the medical community perspectives. In particular, we encourage researchers to submit abstracts within any of the following themes of this symposium.

Proposed Session Topics
  • Synthesis and characterization of novel biomaterials to overcome the blood brain barriers
  • Nanobiomaterials’ applications in neurodegenerative diseases
  • Strategies to enhance the amount and concentration of therapeutic compounds in the brain
  • Drug-release systems for the treatment of Alzheimer’s, Parkinson’s diseases, and amyotrophic lateral sclerosis
  • Nanomaterials as therapeutic agents for patients with brain tumors
  • Surface biofunctionality: The interface between brain implants and living cells and tissues
  • Neurotoxicity and metallic particles
  • Results of clinical evaluations of biomaterials, implants and devices for the treatment of brain disorders
  • Tolou Shokuhfar, Department of Bioengineering, University of Illinois at Chicago, USA,
  • Reza Shahbazian, Department of Mechanical Engineering, University of Illinois at Chicago, USA,
  • Tahaamin Shokuhfar, M.D., Department of Radiology, Feinberg School of Medicine, Section of Neuroradiology, Northwestern University, USA,